The present invention relates to methods and compositions designed for the treatment, management, prevention and/or amelioration of various disorders associated with aberrant expression and/or activity of one or more Eph receptor tyrosine kinase family members and/or one or more Eph receptor ligands, particularly the ephrins. In particular, the invention provides methods for the treatment, management, prevention and/or amelioration of a disorder associated with aberrant expression and/or activity(ies) of one or more Eph receptors and/or one or more ephrins, the method comprising administering to a subject in need thereof an effective amount of one or more Eph/ephrin modulators. The present invention further relates to methods of modulating antibody specificity by tailoring the affinity to cognate antigens.
